GlaxoSmithKline files motion to consolidate Zofran Lawsuits
In July, GlaxoSmithKline, the maker of Zofran, filed a motion to consolidate all outstanding Zofran birth defect lawsuits against the company so that they can be tried in front of one judge. Approximately twelve Zofran lawsuits have been filed in states across the country. The lawsuits claim that the drug is responsible for birth defects suffered by children whose mothers took the drug during the first trimester to combat morning sickness. Some legal experts say the motion to consolidate will be granted because it can benefit both parties in the litigation. Trying similar cases in the same court and in front of the same judge will be a more efficient way to proceed through the litigation.
View article source.